Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations

Details for Australian Patent Application No. 2003226777 (hide)

Owner GBF Gesellschaft Fur Biotechnologische Forschung mbH

Inventors Guzman, Carlos Alberto; Muhlradt, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2003226777

PCT Number PCT/EP03/03497

PCT Pub. Number WO2003/084568

Priority 02007640.2 04.04.02 EP

Filing date 3 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 29 May 2008

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 02007640.2 04.04.02 EP

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003226777

29 May 2008 Application Accepted

  Published as AU-B-2003226777

11 September 2008 Alteration of Name

  The name of the applicant has been altered to Helmholtz-Zentrum fur Infektionsforschung GmbH

25 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003226778-LENTIVIRAL VECTORS DERIVED FROM SIVSMM/PBJ14, METHOD FOR THEIR PRODUCTION AND USES THEREOF

2003226776-Parasite control in animals